Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.
Vasan S, Schlesinger SJ, Huang Y, Hurley A, Lombardo A, Chen Z, Than S, Adesanya P, Bunce C, Boaz M, Boyle R, Sayeed E, Clark L, Dugin D, Schmidt C, Song Y, Seamons L, Dally L, Ho M, Smith C, Markowitz M, Cox J, Gill DK, Gilmour J, Keefer MC, Fast P, Ho DD.
Vasan S, et al. Among authors: gill dk.
PLoS One. 2010 Jan 25;5(1):e8617. doi: 10.1371/journal.pone.0008617.
PLoS One. 2010.
PMID: 20111582
Free PMC article.
Clinical Trial.